In 2023, antidepressant medicine sales in South Korea stood at a value of 5.8 US Dollars Per Capita. From 2024 onward, we see a consistent upward trend in sales. In 2024, sales are forecasted to be 6 USD Per Capita, rising to 6.2 in 2025, 6.5 in 2026, 6.7 in 2027, and 6.9 in 2028.
Year-on-year percentage variations are as follows:- 2024: 3.45%- 2025: 3.33%- 2026: 4.84%- 2027: 3.08%- 2028: 2.99%
The Compound Annual Growth Rate (CAGR) from 2024 to 2028 is approximated at 3.53%.
Future trends to watch for include:- Increasing awareness and diagnosis of mental health issues.- Expansion of healthcare infrastructure and accessibility.- Potential impact of new regulations and healthcare policies.- Introduction of new and more effective antidepressant medications.
